Literature DB >> 2395084

Kaposi's sarcoma in three HIV-1-infected cohorts.

C S Rabkin1, J J Goedert, R J Biggar, F Yellin, W A Blattner.   

Abstract

We describe the Kaposi's sarcoma (KS) experience in three cohorts of homosexual men, subjects with hemophilia, and human immunodeficiency virus type 1 (HIV-1) seroconverters. The risk of KS was higher in HIV-1-infected homosexual men from New York City as compared with Washington, D.C. and was very low in the hemophilia subjects. While KS accounted for a decreasing proportion of AIDS cases in homosexual men, the absolute risk per year did not diminish. Survival was similar after diagnosis of KS vs. opportunistic infection including Pneumocystis carinii pneumonia. Percent CD4+ and CD8+ T cells, and beta 2-microglobulin levels were less abnormal in subjects who later developed KS than in those who developed opportunistic infections; conversely, serum neopterin abnormalities were greater in those who developed KS. The additional risk of KS in homosexual men may explain their apparently higher incidence of AIDS. Further investigation of the differences in intermediate markers of KS and opportunistic infections may shed light on the pathogenesis of these particular manifestations of AIDS.

Entities:  

Mesh:

Year:  1990        PMID: 2395084

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  3 in total

1.  Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men.

Authors:  Chun Chao; Lisa P Jacobson; Frank J Jenkins; Donald Tashkin; Otoniel Martínez-Maza; Michael D Roth; Leslie Ng; Joseph B Margolick; Joan S Chmiel; Zuo-Feng Zhang; Roger Detels
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

2.  Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS.

Authors:  Jean-Saville Cummings; Cristiana Cairo; Cheryl Armstrong; Charles E Davis; C David Pauza
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

3.  Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls.

Authors:  R M Valenti; E Amodio; J-M Nam; L Preiss; B I Graubard; N Romano; J J Goedert
Journal:  Br J Cancer       Date:  2011-01-18       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.